Virax Biolabs Group Limited (VRAX)
NASDAQ·Healthcare·Biotechnology
$2.55
+2.00%
Mkt Cap $868.39K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.00
Range $1.00 – $1.00
Implied Upside
-60.8%
Consensus $1.00 vs current $2.55
NASDAQ·Healthcare·Biotechnology
$2.55
+2.00%
Mkt Cap $868.39K
No recent rating data.
Price Target (1 analysts)
$1.00
Range $1.00 – $1.00
-60.8%
Consensus $1.00 vs current $2.55